Clinical trial of tocilizumab for skin fobrosis in systemic sclerosis
Not Applicable
- Conditions
- Systemic sclerosis
- Registration Number
- JPRN-UMIN000012214
- Lead Sponsor
- The University of Tokyo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 5
Inclusion Criteria
Not provided
Exclusion Criteria
1)during treatment with equal drug 2)previous history of anaphylactic reactions to this drug 3)significant infection 4)significant liver damage 5)significant renal damage 6)pregnancy 7)breast-feeding 8)participating in other clinical trial within three months before the beginni ng of this trial 9)judged inappropriate for this study by the physicians
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sum of skin scores from 17 sites of the body (modified Rodnan total skin score)
- Secondary Outcome Measures
Name Time Method